| dox-sl | <drug> A chemotherapy agent used for Kaposi's sarcoma consisting of a preparation of doxorubicin encapsulated in liposomes which deliver significantly greater quantities of doxorubicin to the KS lesions while reducing the drug's side effects. DOX-SL incorporates so-called stealth liposomes, whose polyethylene glycol (PEG) coating gives them still greater stability in the bloodstream. Side effects include nausea, vomiting, stomatitis, diarrhoea and hair loss. DOX-SL causes a significant amount of neutropenia, which can be managed with G-CSF. (10 Oct 1997) |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|